Drug Approval

Closure of USFDA inspection at Zydus' API Unit at Dabhasa, Gujarat

The inspection concluded with 6 observations and none of them were related to Data Integrity

The USFDA conducted a surveillance inspection at the group's API Unit, located at Dabhasa in Gujarat. The inspection was conducted from April 21st to 25th, 2025.

The inspection concluded with 6 observations and none of them were related to Data Integrity. The company is confident to address the observations expeditiously.

Zydus
USFDA

Upcoming E-conference

Other Related stories

IOL Chemicals and Pharmaceuticals receives approval CDE of NMPA, China for Ibuprofen

Biocon Biologics receives positive CHMP opinions for biosimilar Denosumab in Europe

CuraTeQ Biologics receives positive opinion for biosimilar Dazublys from EMA

Interviews

India rema

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

Capex comm

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Our focus

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Appointments

Abbott India elevates Maithilee Pathare Mistry as CFO

Abbott India elevates Maithilee Pathare Mistry as CFO

Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy

Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy

Shaik Barak Tulla joins Sun Pharma as Sr. VP

Shaik Barak Tulla joins Sun Pharma as Sr. VP

Startup

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh

Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital

Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital

Merck Life Science India signs MoU with DPIIT

Merck Life Science India signs MoU with DPIIT

Digitization

Wanbury to implement the SAP S/4 HANA private cloud platform

Wanbury to implement the SAP S/4 HANA private cloud platform

Rockwell Automation empowers NKP Pharma achieve regulatory compliance

Rockwell Automation empowers NKP Pharma achieve regulatory compliance

Honeywell launches AI-assisted automation platform for life sciences manufacturing industry

Honeywell launches AI-assisted automation platform for life sciences manufacturing industry

Latest Stories

Medanta to set up a 400-bed super specialty hospital in Guwahati

ekincare raises investment from MSD IDEA Studio Asia Pacific

Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr

Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray

IOL Chemicals and Pharmaceuticals receives approval CDE of NMPA, China for Ibuprofen

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Injection filter needle market to reach $1.73 billion in 2025

Injection filter needle market to reach $1.73 billion in 2025

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Interviews

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Dr. R. Ananthanarayanan CEO, Sajjan India

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging

Amcor's Bloom Biorenewables secures $14 million Series A Funding

Amcor's Bloom Biorenewables secures $14 million Series A Funding

Coveris launches circular solution for stretch sleeves with ReCover

Coveris launches circular solution for stretch sleeves with ReCover

UFlex secures USFDA approval for recycled PE in food packaging

UFlex secures USFDA approval for recycled PE in food packaging